Search For "drugs controller"
COVID-19 vaccines 110 pc safe, impotency rumours complete nonsense: DCGI
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency, rubbishing such speculations as "complete nonsense".
Read More
PM Modi congratulates nation, scientists after emergency use approval to C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Prime Minister Narendra Modi congratulated the country as Drugs Controller General of India (DCGI) granted emergency use approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines on Sunday.
Read More
COVID-19 vaccines of SII, Bharat Biotech approved for restricted use in em
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday.
Read More
DCGI to brief media today on COVID-19 vaccine
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
Read More
Recommendation for DCGI nod for restricted emergency use of two COVID-19 v
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): With an expert panel of Drugs Controller General of India (DCGI) recommending grant of restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine on Saturday, doctors said it was a good development as the vaccine i
Read More
COVID-19: Expert committee recommends restricted emergency use of SII, Bha
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of SII, Bharat Biotech's vaccines.
Read More
Expert panel recommends restricted emergency use nod to Bharat Biotech's C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): An expert panel of Drugs Controller General of India (DCGI) has recommended granting restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine, also known as Covaxin, government sources told ANI on Saturday.
Read More
Urdu Bulletin: Expert panel grants emergency use authorisation for vaccine
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): Various editions of Urdu publications have carried the prominent news that the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA) with certain conditions to COVID-1
Read More
Panel recommends to DCGI to grant emergency use authorisation to Serum's C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 1 (ANI) In a major development related to the COVID vaccine, the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA)with certain conditions to COVID-19 vaccine being manufact
Read More
Expert committee to consider SII's emergency use approval for COVID-19 vac
Updated : 5 years, 2 months ago IST
New Delhi [India], December 30 (ANI): Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official.
Read More
Six vaccines currently undergoing clinical trials in India
Updated : 5 years, 3 months ago IST
New Delhi [India], December 15 (ANI): Informing that the Drugs Controller General of India has granted clearance for the clinical trials of one more candidate vaccine from India, NITI Aayog Member (Health) Dr VK Paul on Tuesday said six vaccines are currently undergoing clinical trials in
Read More
DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficac
Updated : 5 years, 3 months ago IST
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
Read More